Equities analysts predict that Re/Max Holdings Inc (NYSE:RMAX) will post earnings per share of $0.42 for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Re/Max’s earnings. Re/Max reported earnings of $0.49 per share during the same quarter last year, which suggests a negative year-over-year growth rate of 14.3%. The firm is scheduled to issue its next earnings results on Thursday, May 2nd.
On average, analysts expect that Re/Max will report full year earnings of $2.07 per share for the current financial year. For the next fiscal year, analysts forecast that the company will post earnings of $2.27 per share. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side analysts that follow Re/Max.
Top 5 Blue Chip Stocks To Watch Right Now: Bayer Aktiengesellschaft (BAYRY)
Bayer AG is a life science company. The Company’s segments are Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment is engaged in the development of prescription pharmaceuticals; contraceptives, and medical products, such as injection systems and contrast agents for diagnostic procedures. The Consumer Health segment is engaged in the development of over-the-counter medications, dermatology products and nutritional supplements. The Crop Science segment is engaged in the development of product portfolio in the areas of seeds and plant traits, crop protection, home and garden, the green industry and nonagricultural pest control. The Animal Health segment is engaged in the development of veterinary medicines and animal grooming products. Covestro is engaged in the development of raw materials for polyurethanes; polycarbonate resins and sheets; raw materials for coatings, adhesives and sealants; and selected chemical intermediates.
- [By ]
Bayer (OTCPK:BAYRY) – Together with Orion Corporation, the company announced that the FDA accepted its New Drug Application and granted Priority Review for darolutamide for the treatment of non-metastatic castration-resistant prostate cancer in the United States. This decision was based on data from the phase III ARAMIS trial – recently, Bayer also submitted an application to the European Medicines Agency and the Ministry of Health, Labor and Welfare in Japan. The drug candidate is thought to have peak sales potential in excess of $1 billion.
- [By ]
Overall, investors need to rely on what is factual and can be referenced. FOTIVDA still outperforms Bayers (OTCPK:BAYRY) Nexavar in PFS and ORR. The preliminary OS data is not complete enough for the FDA and that should be acceptable for investors. In fact, the idea the company had not really addressed the issues from the previous CRL would have prevented me from entering a position prior to the PDUFA date. The market overreacted to the NDA delay news as if it was a CRL. Yes, the company has to hold off on submitting, but the management expects to file an NDA before the end of 2019; which would put the PDUFA date in the second half of 2020.
- [By Cory Renauer]
The first to earn approval, Vitrakvi, treats patients with any type of cancer, as long as their tumors test positive for a specific mutation. Bayer (NASDAQOTH:BAYRY) will market Vitrakvi and send Lilly royalties in a low-30s percentage range on U.S. sales and a tiered double-digit percentage of sales everywhere else.
- [By Todd Campbell]
In the second quarter, Eylea’s net product sales in the U.S. alone were $992 million, up from $919 million last year. Regeneron pocketed $263 million in profit on Eylea’s sales outside the U.S. last quarter, where Bayer AG (NASDAQOTH:BAYRY)markets it. Ex-U.S. revenue reported on Bayer sales in Q2 2017 was $204 million. Overall, Eylea’s global sales totaled $1.66 billion in Q2, giving the drug an annualized sales run rate above $5.2 billion worldwide.
Top 5 Blue Chip Stocks To Watch Right Now: Newmont Mining Corporation(NEM)
Newmont Mining Corporation, together with its subsidiaries, operates in the mining industry. It primarily acquires, develops, explores for, and produces gold, silver, and copper. The companys operations and/or assets are located in the United States, Australia, Peru, Indonesia, Ghana, and Suriname. As of December 31, 2015, it had proven and probable gold reserves of 73.7 million ounces and an aggregate land position of approximately 20,000 square miles. The company was founded in 1916 and is headquartered in Greenwood Village, Colorado.
- [By Neha Chamaria]
In fact, there couldn’t be a better time to buy gold stocks, given the ongoing industry consolidation. Two massive recent deals — Barrick Gold’s (NYSE:GOLD) merger with Randgold Resources and Newmont Mining’s (NYSE:NEM) impending acquisition of Goldcorp (NYSE:GG) — are creating the world’s two largest publicly traded gold mining companies. More recently, Barrick Gold even made a takeover bid for Newmont Mining, but the two gold mining giants have only agreed to combine their operations in Nevada in a joint venture as of this writing. These developments make investing in gold stocks now incredibly interesting.
- [By Chris Hill]
It’s not every day that mining companies make the news here, and that’s because investors are often better off ignoring them. But Barrick Gold(NYSE:GOLD) and Newmont Mining(NYSE:NEM) have been tying up in a big way, creating something to the tune of a $30 billion joint venture in the gold space.
- [By Shane Hupp]
Newmont Mining (NYSE:NEM) has been given a $47.00 target price by equities researchers at Raymond James in a research note issued to investors on Tuesday. The brokerage presently has an “outperform” rating on the basic materials company’s stock. Raymond James’ target price would suggest a potential upside of 36.83% from the company’s current price.
Top 5 Blue Chip Stocks To Watch Right Now: Markel Corporation(MKL)
Markel Corporation markets and underwrites specialty insurance products in the United States and internationally. It operates through three segments: U.S. Insurance, International Insurance, and Reinsurance. The U.S. Insurance segment writes general liability, professional liability, property, personal line, program, workers’ compensation, and other insurance product lines. The International Insurance segment provides professional liability, marine and energy, general liability, property, and other insurance product lines, such as accident and health coverage insurance. The Reinsurance segment offers various treaty reinsurance products, such as property, casualty, auto, and others. Markel Corporation was founded in 1930 and is headquartered in Glen Allen, Virginia.
- [By Jordan Wathen, Matthew Frankel, CFP, and Dan Caplinger]
Below, three Motley Fool contributors make the case for three different insurers with very different business models: Markel (NYSE:MKL), Chubb (NYSE:CB), and First American Financial (NYSE:FAF).
- [By Motley Fool Transcribing]
Markel (NYSE:MKL) Q4 2018 Earnings Conference CallFeb. 6, 2019 9:30 a.m. ET
Prepared Remarks Questions and Answers Call Participants
- [By Steve Symington]
Markel(NYSE:MKL)announced fourth-quarter and full-year 2018 results on Tuesday after the market closed. The diversified insurance and financial holding company detailed seemingly steep losses, albeit driven by a combination of one-time writedowns and new accounting standards that track the fair value of its equity portfolio.
- [By Matthew Frankel, CFP]
Moser: We’re looking forward to that. I’m going to go, on that same wavelength there, our little baby Berkshire that we always call it, Markel (NYSE:MKL), ticker MKL, earnings are coming out on Tuesday. Not a lot that goes on with this business on a quarter-to-quarter basis. It’s pretty consistent. You’ve got the insurance business, you’ve got the Markel Venture side of things. They’ve got their investment portfolio, much like Berkshire Hathaway has. Listeners will recall that there was a little bit of an issue here. They announced there was an investigation into the reinsurance side of the business, specifically it was in regard to reserves. Looking for any clarity on that, and how it could play out on the business here for the coming year. It’s a reserve issue, it doesn’t sound like it’s anything very pivotal to the overall company. But, hey, maybe it plays out on the book value of the company in the short run, and maybe that offers investors an opportunity if there’s a little dip in the stock. This has been one that we’ve owned for long periods of time here in a number of our services here at The Fool, and I suspect that will remain the case regardless of what they say with the earnings release. But hey, if the stock takes a dive, investors may want to take a look at it because it’s still a very good business.
Top 5 Blue Chip Stocks To Watch Right Now: Littelfuse Inc.(LFUS)
Littelfuse, Inc. designs, manufactures, and sells circuit protection devices for use in the automotive, electronic, and electrical markets in the Americas, Europe, and the Asia-Pacific. The company offers electronic circuit protection products, such as fuses and protectors, positive temperature coefficient resettable fuses, varistors, polymer electrostatic discharge suppressors, discrete transient voltage suppression diodes, TVS diode arrays and protection thyristors, gas discharge tubes, and power switching components, as well as fuseholders, blocks, and related accessories under PICO II, and NANO2 SMF, TECCOR, SIDACtor, and Battrax brand names. It offers its electronic circuit protection products for use in wireless telephones, consumer electronics, computers, modems, telecommunications equipment, telephones, data transmission lines, and alarm systems. The company also provides automotive fuses that are used in automobiles, trucks, buses, and off-road equipment to protec t electrical circuits and the wires that supply electrical power to operate lights, heating, air conditioning, radios, windows, and other controls, as well as offers fuses for the protection of electric and hybrid vehicles. It markets its automotive fuse products under ATO, MINI, MAXI, MIDI, MEGA, MasterFuse, JCASE, and CablePro brand names. In addition, Littelfuse manufactures various low-voltage and medium-voltage circuit protection products, such as power fuses that are used in the protection from over-load and short-circuit currents in motor branch circuits, heating and cooling systems, control systems, lighting circuits, and electrical distribution networks to electrical distributors and their customers in the construction, original equipment manufacturers, and industrial maintenance and repair and operating supplies markets. Littelfuse sells its products through direct sales force and manufacturers? representatives. The company was founded in 1927 and is headquartered in Chicago, Illinois.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Littelfuse (LFUS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Littelfuse, Inc. (NASDAQ:LFUS) – Research analysts at Barrington Research reduced their Q3 2019 earnings estimates for Littelfuse in a research note issued to investors on Thursday, January 31st. Barrington Research analyst G. Prestopino now forecasts that the technology company will post earnings per share of $2.76 for the quarter, down from their prior forecast of $2.81. Barrington Research has a “Hold” rating on the stock. Barrington Research also issued estimates for Littelfuse’s Q4 2019 earnings at $2.35 EPS, Q2 2020 earnings at $2.91 EPS and FY2020 earnings at $10.63 EPS.
Top 5 Blue Chip Stocks To Watch Right Now: SuperCom, Ltd.(SPCB)
SuperCom Ltd. provides traditional and digital identity solutions to governments, and private and public organizations worldwide. The company offers real-time positioning, tracking, monitoring, and verification solutions enabled by its PureRF wireless hybrid suite of products and technologies that are connected to a Web-based interactive interface. Its PureRF suite is a location position system solution based on active radio frequency identification (RFID) tag technology that enables commercial customers and governmental agencies to identify, locate, track, monitor, count, and protect people and objects. The companys PureRF suite provides various product components, such as PureRF tags, hands-free long-range RFID asset tags, hands-free long-range RFID vehicle tags, PureRF readers, PureRF activators, and PureRF Initializer. In addition, it provides house arrest monitoring systems, GPS offender tracking systems, PureMonitor offender electronic monitoring software, inmate monitoring systems, and domestic violence victim protection systems. Further, the company offers national identification registries, e-passports, biometric visas, automated fingerprint identification systems, digitized drivers licenses, and electronic voter registration and election management through the companys MAGNA common platform to the law enforcement agencies, community safety agencies, and the ministries of justice. Additionally, it provides SuperPay, a secure mobile payment hybrid suite; PureMoney Suite that provides mobile money applications and services; and SuperPOS, a platform to perform mobile payments. It sells its systems and products through local representatives, subsidiaries, resellers, and distribution channels that include direct sales and sales through traditional distributors or resellers. The company was formerly known as Vuance Ltd. and changed its name to SuperCom Ltd. in January 2013. SuperCom Ltd. was founded in 1988 and is headquartered in Herzliya, Israel.
- [By Stephan Byrd]
SuperCom (NASDAQ:SPCB) and CEVA (NASDAQ:CEVA) are both small-cap industrial products companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk and analyst recommendations.
- [By Alexander Bird]
Here are the top performers from last week…
Penny Stock Current Share Price Last Week’s Gain
Aegean Marine Petroleum Network Inc. (NYSE: ANW) $1.83 165.71%
Radisys Corp. (Nasdaq: RSYS) $1.55 115.68%
Ascent Capital Group Inc. (Nasdaq: ASCMA) $3.71 43.12%
Adamis Pharmaceuticals Corp. (Nasdaq: ADMP) $4.36 40.63%
Tintri Inc. (Nasdaq: TNTR) $0.18 40.49%
Prana Biotechnology Ltd. (Nasdaq: PRAN) $2.35 39.96%
Micronet Enertec Technologies Inc. (Nasdaq: MICT) $1.60 39.40%
Corindus Vascular Robotics (NYSE: CVRS) $1.17 34.40%
ParkerVision Inc. (Nasdaq: PRKR) $0.70 30.65%
SuperCom Ltd. (Nasdaq: SPCB) $0.24 30.10%
While these gains are exciting, they pale in comparison to the profit potential of our top penny stock to buy this week.